Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.
about
Neuroplasticity and the next wave of antidepressant strategiesLateral prefrontal cortex mediates the cognitive modification of attentional biasDoes non-invasive brain stimulation applied over the dorsolateral prefrontal cortex non-specifically influence mood and emotional processing in healthy individuals?Novel Primate Model of Serotonin Transporter Genetic Polymorphisms Associated with Gene Expression, Anxiety and Sensitivity to Antidepressants.The effects of drugs on human models of emotional processing: an account of antidepressant drug treatmentA neurocognitive model for understanding treatment action in depressionCognitive mechanisms of diazepam administration: a healthy volunteer model of emotional processing.fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.Project PAVE (Personality And Vision Experimentation): role of personal and interpersonal resilience in the perception of emotional facial expression.'Can you look me in the face?' Short-term SSRI administration reverts avoidant ocular face exploration in subjects at risk for psychopathology.Affective cognition and its disruption in mood disorders.The impact of intranasal oxytocin on attention to social emotional stimuli in patients with anorexia nervosa: a double blind within-subject cross-over experiment.Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers.Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety.Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior.Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases.A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression.Attentional bias in older adults: effects of generalized anxiety disorder and cognitive behavior therapy.The neurobiology of dispositional negativity and attentional biases to threat: Implications for understanding anxiety disorders in adults and youth.The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies.Efficacy markers in depression.Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder.Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?Mechanisms of Selective Attention in Generalized Anxiety Disorder.Does melatonin treatment change emotional processing? Implications for understanding the antidepressant mechanism of agomelatine.Treatment Associated Changes of Functional Connectivity of Midbrain/Brainstem Nuclei in Major Depressive Disorder.Effects of short-term quetiapine treatment on emotional processing, sleep and circadian rhythms.Serotoninergic effects on judgments and social learning of trustworthiness.Short-term NK1 receptor antagonism and emotional processing in healthy volunteers.The Nature, Diagnosis, and Treatment of Neuroticism
P2860
Q21129480-960FA8FA-6F03-46C3-A54D-47E0693C5F38Q24625336-B10954C0-897A-41F5-996D-CED79521F379Q26777272-DC9C2810-34BA-4BA4-9735-CF0B3DD56E2BQ27310483-F18D842A-6736-4BC4-8EE7-FCFEB2D1A747Q28072345-1B2D71AA-9C83-49BF-9B6B-9060F7E1738FQ30374324-A70A57C2-E04B-4CB9-BB58-8E7FB8415D2DQ30381167-A143267D-E7DB-4CA1-BF3B-71DD06747EB2Q33853141-110ABD8D-BE7F-4971-9594-935F940CE506Q34039670-A947CD3C-0E74-4CF4-8A38-5D64667A4C8BQ34499333-0DE58D8F-40D1-4E98-B244-7FD8CABA4746Q34661207-015E02EB-E7D8-4518-9C65-E67A6F060F5DQ35113263-B5F83150-9A01-4832-AFC5-32EB6A985373Q35539450-19B0EEBE-D3DA-4B2F-824B-25D7E6EE1DA1Q35544194-565B3FAB-8617-43E6-91BB-BCD75E65D4AAQ36174404-F4C716FE-A379-48E0-855F-A9C06F93D904Q36613432-E52070AF-B248-48AB-942C-1C8E91D5781EQ37078954-46433DDC-25E0-4862-8C1D-971F924E30C8Q37278278-3E12AA9B-1281-4840-9969-33B94D80FD9BQ37458611-74A3E42C-D425-4AAE-9DB0-E40AF2CBD304Q37763406-D8A5B63D-AE6B-421B-B26F-C52D7C77DB20Q37763408-B65104B3-A5FB-48F4-BA61-53DE17F111AFQ38016563-B9813CA7-F53E-45CA-B169-FA2457775F3EQ38080019-CA8DFB6B-F23E-419C-9B77-55CC2A18C34DQ40389347-47EC5EAA-5C0A-4598-B8C7-5BA697AF06CAQ40737578-B004A102-8284-4E3B-B85A-6929937F7CC5Q41447372-4A184813-01D8-4B75-94A1-6A72A48E8C2AQ47584876-4BE720CC-6B2E-45BA-96BC-CFAB3FE1C177Q48364109-9DE4672E-15AE-4A3E-836B-DC11EB0D5AA0Q50653572-417A13AC-6C37-4834-8808-E4C0F837F519Q56806514-99D5AA22-2EC2-43F2-8872-CAE0321EAF1B
P2860
Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Short-term serotonergic but no ...... threat in healthy volunteers.
@en
type
label
Short-term serotonergic but no ...... threat in healthy volunteers.
@en
prefLabel
Short-term serotonergic but no ...... threat in healthy volunteers.
@en
P50
P1476
Short-term serotonergic but no ...... threat in healthy volunteers.
@en
P304
P356
10.1017/S1461145708009164
P577
2008-08-28T00:00:00Z